The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Declerck, Paul, Danesi, Romano, Petersel, Danielle, Jacobs, Ira
Published in Drugs (New York, N.Y.) (01.04.2017)
Published in Drugs (New York, N.Y.) (01.04.2017)
Get full text
Journal Article
Emerging therapeutic targets for patients with advanced prostate cancer
Saad, Fred, Shore, Neal, Zhang, Tian, Sharma, Shikhar, Cho, Helen K., Jacobs, Ira A.
Published in Cancer treatment reviews (01.06.2019)
Published in Cancer treatment reviews (01.06.2019)
Get full text
Journal Article
Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics
Davda, Jasmine, Declerck, Paul, Hu-Lieskovan, Siwen, Hickling, Timothy P, Jacobs, Ira A, Chou, Jeffrey, Salek-Ardakani, Shahram, Kraynov, Eugenia
Published in Journal for immunotherapy of cancer (15.04.2019)
Published in Journal for immunotherapy of cancer (15.04.2019)
Get full text
Journal Article
Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study
Chawla, Sant, Dr, Henshaw, Robert, Prof, Seeger, Leanne, Prof, Choy, Edwin, MD, Blay, Jean-Yves, MD, Ferrari, Stefano, MD, Kroep, Judith, MD, Grimer, Robert, DSc, Reichardt, Peter, MD, Rutkowski, Piotr, Prof, Schuetze, Scott, MD, Skubitz, Keith, Prof, Staddon, Arthur, MD, Thomas, David, FRACP, Qian, Yi, PhD, Jacobs, Ira, MD
Published in The lancet oncology (01.08.2013)
Published in The lancet oncology (01.08.2013)
Get full text
Journal Article
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma
Noel, Marcus, O’Reilly, Eileen M., Wolpin, Brian M., Ryan, David P., Bullock, Andrea J., Britten, Carolyn D., Linehan, David C., Belt, Brian A., Gamelin, Eric C., Ganguly, Bishu, Yin, Donghua, Joh, Tenshang, Jacobs, Ira A., Taylor, Carrie T., Lowery, Maeve A.
Published in Investigational new drugs (01.06.2020)
Published in Investigational new drugs (01.06.2020)
Get full text
Journal Article
Barriers to the Use of Trastuzumab for HER2+ Breast Cancer and the Potential Impact of Biosimilars: A Physician Survey in the United States and Emerging Markets
Lammers, Philip, Criscitiello, Carmen, Curigliano, Giuseppe, Jacobs, Ira
Published in Pharmaceuticals (Basel, Switzerland) (17.09.2014)
Published in Pharmaceuticals (Basel, Switzerland) (17.09.2014)
Get full text
Journal Article
The Promise for Histone Methyltransferase Inhibitors for Epigenetic Therapy in Clinical Oncology: A Narrative Review
Rugo, Hope S., Jacobs, Ira, Sharma, Shikhar, Scappaticci, Frank, Paul, Thomas A., Jensen-Pergakes, Kristen, Malouf, Gabriel G.
Published in Advances in therapy (01.07.2020)
Published in Advances in therapy (01.07.2020)
Get full text
Journal Article
Considerations in the early development of biosimilar products
Li, Edward C., Abbas, Richat, Jacobs, Ira A., Yin, Donghua
Published in Drug discovery today (01.05.2015)
Published in Drug discovery today (01.05.2015)
Get full text
Journal Article